Anita Kavlie
Position: Scientist, PhD
Phone: +47 23 07 14 52
Email:
 

Publications 2013

Thomas M, Kienast Y, Scheuer W, Bähner M, Kaluza K, Gassner C, Herting F, Brinkmann U, Seeber S, Kavlie A, Welschof M, Ries S, Weidner KM, Regula JT, Klein C (2013)
A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors
PLoS One, 8 (2), e54923
PubMed 23405099

Publications 2010

Moody MA, Liao HX, Alam SM, Scearce RM, Plonk MK, Kozink DM, Drinker MS, Zhang R, Xia SM, Sutherland LL, Tomaras GD, Giles IP, Kappes JC, Ochsenbauer-Jambor C, Edmonds TG, Soares M, Barbero G, Forthal DN, Landucci G, Chang C, King SW, Kavlie A, Denny TN, Hwang KK, Chen PP et al. (2010)
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines
J Exp Med, 207 (4), 763-76
PubMed 20368576

Sullivan LA, Carbon JG, Roland CL, Toombs JE, Nyquist-Andersen M, Kavlie A, Schlunegger K, Richardson JA, Brekken RA (2010)
r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction
PLoS One, 5 (8), e12031
PubMed 20700512

Publications 2005

Løset GÅ, Løbersli I, Kavlie A, Stacy JE, Borgen T, Kausmally L, Hvattum E, Simonsen B, Hovda MB, Brekke OH (2005)
Construction, evaluation and refinement of a large human antibody phage library based on the IgD and IgM variable gene repertoire
J Immunol Methods, 299 (1-2), 47-62
PubMed 15914190

Publications 2004

Kavlie A, Wiiger MT, Husbyn M, Stormorken H, Prydz H (2004)
A novel gene mutation in the 60s loop of human coagulation factor VII - inhibition of interdomain crosstalk
Thromb Haemost, 91 (1), 28-37
PubMed 14691565

Publications 2003

Kavlie A, Hiltunen L, Rasi V, Prydz H (2003)
Two novel mutations in the human coagulation factor VII promoter
Thromb Haemost, 90 (2), 194-205
PubMed 12888866